Literature DB >> 26511007

The role of procalcitonin as a marker of diabetic foot ulcer infection.

Mafalda Massara1,2, Giovanni De Caridi2, Raffaele Serra3,4, David Barillà1, Andrea Cutrupi5, Alberto Volpe6, Francesco Cutrupi1, Antonino Alberti1, Pietro Volpe1.   

Abstract

Foot ulcers are frequent in diabetic patients and are responsible for 85% of amputations, especially in the presence of infection. The diagnosis of diabetic foot ulcer infection is essentially based on clinical evaluation, but laboratory parameters such as erythrocyte sedimentation rate (ESR), white blood count (WBC), C-reactive protein (CRP) and, more recently, procalcitonin (PCT) could aid the diagnosis, especially when clinical signs are misleading. Fifteen diabetic patients with infected foot ulcers were admitted to our department and were compared with an additional group of patients with non-infected diabetic foot ulcers (NIDFUs). Blood samples were collected from all patients in order to evaluate laboratory markers. In the current study, the diagnostic accuracy of PCT serum levels was evaluated in comparison with other inflammatory markers such as CRP, ESR and WBC as an indicator to make the distinction between infected diabetic foot ulcers (IDFUs) and NIDFUs. CRP, WBC, ESR and especially PCT measurements represent effective biomarkers in the diagnosis of foot infections in diabetic patients particularly when clinical signs are misleading.
© 2015 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  C-reactive protein; Diabetic foot ulcers; Infection; Procalcitonin

Mesh:

Substances:

Year:  2015        PMID: 26511007      PMCID: PMC7950008          DOI: 10.1111/iwj.12536

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  23 in total

1.  Diagnosis and treatment of diabetic foot infections.

Authors:  Benjamin A Lipsky; Anthony R Berendt; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Jack L LeFrock; Daniel P Lew; Jon T Mader; Carl Norden; James S Tan
Journal:  Clin Infect Dis       Date:  2004-09-10       Impact factor: 9.079

Review 2.  The global burden of diabetic foot disease.

Authors:  Andrew J M Boulton; Loretta Vileikyte; Gunnel Ragnarson-Tennvall; Jan Apelqvist
Journal:  Lancet       Date:  2005-11-12       Impact factor: 79.321

3.  Value of white blood cell count with differential in the acute diabetic foot infection.

Authors:  D G Armstrong; T A Perales; R T Murff; G W Edelson; J G Welchon
Journal:  J Am Podiatr Med Assoc       Date:  1996-05

4.  Risk factors for foot infections in individuals with diabetes.

Authors:  Lawrence A Lavery; David G Armstrong; Robert P Wunderlich; M Jane Mohler; Christopher S Wendel; Benjamin A Lipsky
Journal:  Diabetes Care       Date:  2006-06       Impact factor: 19.112

5.  C-reactive protein and glycemic control in adults with diabetes.

Authors:  Dana E King; Arch G Mainous; Thomas A Buchanan; William S Pearson
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

6.  The epidemiology of lower-extremity disease in veterans with diabetes.

Authors:  Jennifer A Mayfield; Gayle E Reiber; Charles Maynard; Joseph Czerniecki; Bruce Sangeorzan
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

Review 7.  Preventive foot care in people with diabetes.

Authors:  J A Mayfield; G E Reiber; L J Sanders; D Janisse; L M Pogach
Journal:  Diabetes Care       Date:  1998-12       Impact factor: 19.112

8.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

Review 9.  A report from the international consensus on diagnosing and treating the infected diabetic foot.

Authors:  Benjamin A Lipsky
Journal:  Diabetes Metab Res Rev       Date:  2004 May-Jun       Impact factor: 4.876

10.  Can procalcitonin be an accurate diagnostic marker for the classification of diabetic foot ulcers?

Authors:  Nematollah Jonaidi Jafari; Mahdi Safaee Firouzabadi; Morteza Izadi; Mohammad Sadegh Safaee Firouzabadi; Amin Saburi
Journal:  Int J Endocrinol Metab       Date:  2014-01-05
View more
  9 in total

1.  Pentraxin-3: A new parameter in predicting the severity of diabetic foot infection?

Authors:  Safak Ozer Balin; Ayse Sagmak Tartar; Kader Uğur; Faruk Kilinç; Selda Telo; Ali Bal; Mehmet Balin; Ayhan Akbulut
Journal:  Int Wound J       Date:  2019-02-15       Impact factor: 3.315

Review 2.  Advanced Wound Diagnostics: Toward Transforming Wound Care into Precision Medicine.

Authors:  Maximillian A Weigelt; Hadar A Lev-Tov; Marjana Tomic-Canic; W David Lee; Ryan Williams; David Strasfeld; Robert S Kirsner; Ira M Herman
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-07-21       Impact factor: 4.730

3.  Levels of wound calprotectin and other inflammatory biomarkers aid in deciding which patients with a diabetic foot ulcer need antibiotic therapy (INDUCE study).

Authors:  J R Ingram; S Cawley; E Coulman; C Gregory; E Thomas-Jones; T Pickles; R Cannings-John; N A Francis; K Harding; K Hood; V Piguet
Journal:  Diabet Med       Date:  2017-08-15       Impact factor: 4.359

4.  The Role of Serum Procalcitonin, Interleukin-6, and Fibrinogen Levels in Differential Diagnosis of Diabetic Foot Ulcer Infection.

Authors:  Pınar Korkmaz; Havva Koçak; Kevser Onbaşı; Polat Biçici; Ahmet Özmen; Cemile Uyar; Duru Mıstanoğlu Özatağ
Journal:  J Diabetes Res       Date:  2018-02-21       Impact factor: 4.011

5.  Role of Procalcitonin as a Predictor of Clinical Outcome in Acute Diabetic Foot Infections: A Prospective Study.

Authors:  Adlyne R Asirvatham; Usha Menon; Praveen V Pavithran; Jayakumar R Vasukutty; Harish Kumar; Nisha Bhavani; Arun Menon; Vasantha Nair; Vivek Lakshmanan; Ajit K Varma; Mangalanandan T Sukumaran; Arun Bal
Journal:  Indian J Endocrinol Metab       Date:  2019 Jan-Feb

6.  Pro-Calcitonin, Erythrocyte Sedimentation Rate and C - reactive Protein in Predicting Diabetic Foot Ulcer Characteristics; a Cross Sectional Study.

Authors:  Fahimeh Hadavand; Atefeh Amouzegar; Hessam Amid
Journal:  Arch Acad Emerg Med       Date:  2019-07-10

Review 7.  Electrospun nanofibers as a wound dressing for treating diabetic foot ulcer.

Authors:  Yan Liu; Shiya Zhou; Yanlin Gao; Yinglei Zhai
Journal:  Asian J Pharm Sci       Date:  2018-05-10       Impact factor: 6.598

Review 8.  The Role of Matrix Metalloproteinases in Diabetic Wound Healing in relation to Photobiomodulation.

Authors:  Sandra Matabi Ayuk; Heidi Abrahamse; Nicolette Nadene Houreld
Journal:  J Diabetes Res       Date:  2016-05-23       Impact factor: 4.011

9.  Procalcitonin levels and other biochemical parameters in patients with or without diabetic foot complications.

Authors:  Shatha Abdul Wadood Al-Shammaree; Banan Akram Abu-ALkaseem; Isam N Salman
Journal:  J Res Med Sci       Date:  2017-08-16       Impact factor: 1.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.